ManaT Bio has filed a notice of an exempt offering of securities to raise $152,960,126.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, ManaT Bio is raising $152,960,126.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Cary Pfeffer played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About ManaT Bio
ManaT Bio is developing off-the-shelf therapeutics discovered from novel observations in genetics and immunology targeted to treating patients with deep unmet need.
To learn more about ManaT Bio, visit http://www.manatbio.com/
Contact:
Cary Pfeffer, Chief Executive Officer
301-615-0491
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.